SK Bioscience

South Korea-US stock market struck again by fear of inflation…SK Basa reverses decline, rather than “tasang”

[경제]SK Bioscience’s’Double Upper Limit’ … 28th in the market cap at once

SK Bioscience goes directly to’Tasang’… 740 million money cushion per employee

A Korean company where most of its employees earn 800 million in one day.

SK Bioscience Public Offering Stock Subscribers Conflict’Happiness’ in Choosing a Securities Company

‘IPO Daewoo’ SK Bioscience subscription for two days… Shall we go’Dad

The NovaVax vaccine is produced by SK Bioscience… Supply contract signed today: Dong-A Science

[금일 제약업계 주요기사] Celltrion antibody treatment’approved’… Bukwang Pharmaceutical “Corona 19 treatment, clinical phase 2 IND approval by the US FDA, etc.

“SK-developed corona vaccine, phase 3 clinical trial after securing interim results in the third quarter”

SK Bioscience’s’corona vaccine’ begins phase 1 clinical trial

[금일 제약업계 주요기사]The first corona19 vaccine in Korea?… SK Bioscience, Covid-19 vaccine distribution

Corona 19 vaccine imminent in Korea… Which vaccine will be approved first?